Healthcare Services US

US Pharmaceutical Cold Chain Logistics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Pharmaceutical Cold Chain Logistics Market Industry Trends and Forecast to 2034: Segmented by (Service, Temperature, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $8.69 Bn Placeholder estimate
Estimate 2025 $9.21 Bn 41.6% of the global market
Projected 2034 $15.56 Bn 68.9% Adds $6.35 Bn over 9 forecast years
CAGR 2025–2034 6.0% Faster than 37% of 107 Healthcare Services markets here
Key players 5 Companies profiled
  • US is 41.55% of the global market.
  • In North America, the largest is US (this report) at $9.21 Bn.
  • Fastest growing: Canada at 8.2% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$6.35 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Pharmaceutical Cold Chain Logistics Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $8.69 Bn — —
2025 (base) $9.21 Bn +$521.2 Mn —
2026 (forecast) $9.76 Bn +$552.5 Mn +6%
2027 (forecast) $10.35 Bn +$585.7 Mn +12.4%
2028 (forecast) $10.97 Bn +$620.8 Mn +19.1%
2029 (forecast) $11.63 Bn +$658.0 Mn +26.2%
2030 (forecast) $12.32 Bn +$697.5 Mn +33.8%
2031 (forecast) $13.06 Bn +$739.4 Mn +41.9%
2032 (forecast) $13.85 Bn +$783.7 Mn +50.4%
2033 (forecast) $14.68 Bn +$830.8 Mn +59.4%
2034 (forecast) $15.56 Bn +$880.6 Mn +68.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Pharmaceutical Cold Chain Logistics Market Analysis at a glance
Market size, 2025$9.21 Bn placeholder estimate
Forecast, 2034$15.56 Bn placeholder estimate
Growth (CAGR), 2025–20346.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsService, temperature and end user (see all)
Key playersDHL Supply Chain, UPS Healthcare, FedEx, Kuehne+Nagel, Cencora (World Courier) (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Pharmaceutical Cold Chain Logistics Market Analysis Executive Summary

Pharmaceutical cold chain logistics keeps vaccines, biologics and other temperature-sensitive medicines at the right temperature during transport and storage.

Key segments of the pharmaceutical Cold Chain Logistics market include service (Storage, Transportation and Packaging) and temperature (Frozen, Refrigerated and Controlled Room Temperature).

Bar chart: US Pharmaceutical Cold Chain Logistics market size, 2024–2034, placeholder estimates. $8.69 Bn in 2024, $9.21 Bn in 2025 and $15.56 Bn in 2034, 6.0% CAGR.
US Pharmaceutical Cold Chain Logistics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Pharmaceutical Cold Chain Logistics Market Dynamics

Market Growth Drivers

Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the pharmaceutical Cold Chain Logistics market. Many companies now outsource work they used to do in-house.

Opportunity

Advanced therapies, AI-driven operations and expansion in India, China and Southeast Asia give the pharmaceutical Cold Chain Logistics market room to grow.

Market Restraints

Capacity shortages, strict quality rules, data security concerns and pricing pressure hold back the pharmaceutical Cold Chain Logistics market.

Competitive Landscape for Pharmaceutical Cold Chain Logistics Market in US

The pharmaceutical Cold Chain Logistics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Pharmaceutical Cold Chain Logistics Market in US

Pharmaceutical Cold Chain Logistics in the US: payment

Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[1]

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how pharmaceutical Cold Chain Logistics services are delivered and paid for in US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Pharmaceutical Cold Chain Logistics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Pharmaceutical Cold Chain Logistics in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Pharmaceutical Cold Chain Logistics market in the US?
Placeholder estimate: about $9.21 Bn in 2025, rising to about $15.56 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Pharmaceutical Cold Chain Logistics market in the US growing?
Placeholder estimate: about 6.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Pharmaceutical Cold Chain Logistics market report cover?
The report splits the market by service (Storage, Transportation, Packaging, Monitoring), temperature (Frozen, Refrigerated, Controlled Room Temperature) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Pharmaceutical Cold Chain Logistics market?
Key players include DHL Supply Chain, UPS Healthcare, FedEx, Kuehne+Nagel and Cencora (World Courier).
What is driving the Pharmaceutical Cold Chain Logistics market?
Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the pharmaceutical Cold Chain Logistics market. Many companies now outsource work they used to do in-house.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in US

See all

Related on drug development and manufacturing and biologics and biosimilars

See the topic